Schulich-UWindsor Opportunities for Research Excellence Program
This summer, 10 Windsor Campus students will participate in the Schulich-UWindsor Opportunities for Research Excellence Program. Their research will cover a wide range of topics from prostate cancer to diiferential diagnosis of epilepsy and psychogenic non-epileptic seizures.
Congratulations to the following students:
Paul Dolnar, Medicine Class of 2018
Working with Dr. Khalid Hirmiz – A retrospective chart of review of patients diagnosed with rectal cancer, treated at the Windsor Cancer Centre between 2002 and 2010, examining treatments and outcomes.
Ala El Babab, Medicine Class of 2019
Working with Dr. Patti A. Timmons Fritz – Relations among adolescent dating aggression and psychological, somatic and adaptive functioning.
Robert Jie Guo, Medicine Class of 2019
Working with Dr. Sindu Kanjeekal – Retrospective review of CNS prophylaxis and outcomes in patients.
Aram Karkar, Medicine Class of 2019
Working with Dr. Luis Rveda – Biological analysis of transcriptve biomarkers for prostate cancer progression.
Katie Kent, Medicine Class of 2019
Working with Dr. Lazlo Erdodi – The doubtful benefits of giving the benefit of the doubt: Lenient scoring of the spatial orientation items on the mini-mental status exam increases false negative rates.
Shannon Baker, Medicine Class of 2019
Working with Lazlo Erdodi – Differential diagnosis of epilepsy and psychogenic non-epileptic seizures.
Matthew Greenacre, Medicine Class of 2019
Working with Lazlo Erdodi – Differentiating cognitive assessment scores of mild traumatic brain injury and psychiatric patients.
Anna Merzwa, Medicine Class of 2018
Working with Dr. Phillip Karpowicz – Intestinal stem cell and epithelium expression of circadian clock targets.
Jennifer Nguyen, Medicine Class of 2018
Working with Dr. Caroline Hamm – Development of a taxotere/Carboplatin protocol for the treatment of triple negative breast cancer.
Hong Yu (Andrew) Su, Medicine Class of 2019
Working with Dr. Swati Kulkarni – To investigate characteristics, treatment patters and outcome of breats cancer patients 40 years or under at the time of diagnosis.
